STOCK TITAN

ZVRA (ZVRA) insider plans sale of 105,625 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 discloses a planned sale of 105,625 shares of common stock, with an aggregate market value of $950,625.00. The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ around 02/02/2026.

The securities were acquired on 01/31/2026 as restricted stock units from the issuer, with the same date listed for payment and the nature of payment marked as N/A. The signer represents they are not aware of undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the ZVRA Form 144 filing disclose about planned share sales?

The filing shows a planned sale of 105,625 common shares with an aggregate market value of $950,625.00. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ around 02/02/2026.

How were the 105,625 ZVRA shares in this Form 144 acquired?

The shares were acquired on 01/31/2026 as restricted stock units from the issuer. The table lists 105,625 securities acquired on that date, with the nature of payment shown as “N/A,” indicating no separate cash purchase price in this record.

Which broker is handling the planned ZVRA share sale in this Form 144?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. The filing lists this broker for executing the sale of 105,625 common shares on NASDAQ.

What market information is provided about the ZVRA shares in this Form 144?

The filing states an aggregate market value of $950,625.00 for the 105,625 common shares to be sold. It also specifies that the planned transaction will occur on the NASDAQ, giving investors context on venue and implied pricing of the proposed sale.

What representation does the seller make in the ZVRA Form 144 notice?

By signing, the seller represents they do not know of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. This representation is a standard requirement when filing a Form 144 notice of proposed sales.
Zevra Therapeutics Inc

NASDAQ:ZVRA

ZVRA Rankings

ZVRA Latest News

ZVRA Latest SEC Filings

ZVRA Stock Data

526.94M
54.85M
0.69%
65.12%
12.28%
Biotechnology
Pharmaceutical Preparations
Link
United States
CELEBRATION